The University of Oxford and AstraZeneca’s coronavirus vaccine was 90 percent effective in preventing COVID-19 in clinical trials, AstraZeneca said in a November 23 press release.
The University of Oxford and AstraZeneca’s coronavirus vaccine was 90 percent effective in preventing COVID-19 in clinical trials, AstraZeneca said in a November 23 press release.